Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ARDS

Rasburicase is a recombinant urate-oxidase enzyme and is a very important medication for tumor lysis syndrome. Methemoglobinemia and hemolysis are known side effects of rasburicase that result from oxidative stress caused by hydrogen peroxide, a byproduct generated during the breakdown of uric acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Raru, Yonas, Abouzid, Mahmoud, Parsons, Julia, Zeid, Fuad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307101/
https://www.ncbi.nlm.nih.gov/pubmed/30603605
http://dx.doi.org/10.1016/j.rmcr.2018.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307101/
https://www.ncbi.nlm.nih.gov/pubmed/30603605
http://dx.doi.org/10.1016/j.rmcr.2018.12.011

Ejemplares similares